Trevor Smith
YOU?
Author Swipe
View article: High-protein oral nutritional supplement use in patients with cancer reduces complications and length of hospital stay: a systematic review and meta-analysis
High-protein oral nutritional supplement use in patients with cancer reduces complications and length of hospital stay: a systematic review and meta-analysis Open
Introduction Oral nutritional supplements (ONS) have been reported to improve nutritional status, quality of life and clinical outcomes in many patient groups. This systematic review investigated the effects of high-protein ONS (HPONS), ≥2…
View article: Management of type 1 (acute) intestinal failure
Management of type 1 (acute) intestinal failure Open
Intestinal failure (IF) is defined as ‘the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/o…
View article: Scalable Cost-Optimized HPC Cluster on Google Cloud Platform
Scalable Cost-Optimized HPC Cluster on Google Cloud Platform Open
High-Performance Computing (HPC) clusters are essential for researchers handling complex computational tasks and big data analysis; yet, access to these powerful resources remains constrained. Most researchers rely on shared super-computin…
View article: Randomised Trial Shows Readymade Oral Nutritional Supplements in Older Malnourished People in the Community Improve Total Nutrient Intakes and Meet More Dietary Reference Values Without Reducing Intake from the Diet
Randomised Trial Shows Readymade Oral Nutritional Supplements in Older Malnourished People in the Community Improve Total Nutrient Intakes and Meet More Dietary Reference Values Without Reducing Intake from the Diet Open
Background: There is little information about the effectiveness of oral nutritional supplements (ONS) in combatting nutrient inadequacies in primary care, where most malnutrition exists. Aim: To examine the extent to which readymade ONS ad…
View article: Placebo Effect Sizes in Clinical Trials of Knee Osteoarthritis Using Intra‐Articular Injections of Biologic Agents
Placebo Effect Sizes in Clinical Trials of Knee Osteoarthritis Using Intra‐Articular Injections of Biologic Agents Open
Objective Patients with knee osteoarthritis rely on symptomatic treatments, in which up to 75% of the pain reduction can be attributed to the placebo effect. This effect may vary based on treatment type (eg, biologics vs nonbiologic inject…
View article: Human-Centered Design and Iterative Refinement of Tools and Methods to Implement a Surveillance and Risk Prediction System for Clinical Deterioration in Ambulatory Cancer Care
Human-Centered Design and Iterative Refinement of Tools and Methods to Implement a Surveillance and Risk Prediction System for Clinical Deterioration in Ambulatory Cancer Care Open
Background A common cause of preventable harm is the failure to detect and appropriately respond to clinical deterioration. Timely intervention is needed, particularly in medically complex patients, to mitigate the effects of adverse event…
View article: Understanding health inequalities through emergency department walk-in data
Understanding health inequalities through emergency department walk-in data Open
Introduction: Emergency Departments are under considerable pressure, with the number of attendances increasing alongside a considerable backlog of patients waiting for treatment. Across England, A&E attendances and emergency admissions in …
View article: Damage to medical complexes in the Gaza Strip during the Israel–Hamas war: a geospatial analysis
Damage to medical complexes in the Gaza Strip during the Israel–Hamas war: a geospatial analysis Open
Introduction Medical facilities are civilian objects specially protected during armed conflict by international humanitarian law (IHL). These protections are customarily applied regardless of the conflict, parties or contexts involved. Att…
View article: Gastroenterology trainee experience, confidence and satisfaction in nutrition training: a cross-sectional survey in the UK
Gastroenterology trainee experience, confidence and satisfaction in nutrition training: a cross-sectional survey in the UK Open
Introduction Nutrition is an essential part of gastroenterology specialist training. There is limited evidence of trainee experience in this area. The shorter training programme introduced in 2022 may lead to reduced exposure to this subsp…
View article: Follow-up of patients with coeliac disease: Experience from a virtual clinic
Follow-up of patients with coeliac disease: Experience from a virtual clinic Open
View article: A systematic review and meta-analysis of the effects of community use of oral nutritional supplements on clinical outcomes
A systematic review and meta-analysis of the effects of community use of oral nutritional supplements on clinical outcomes Open
The impact of oral nutritional supplements (ONS) on patients with complications (disease related morbidity) requires further exploration. This systematic review included 44 randomised controlled trials (RCT) (29 RCT surgical, 15 RCT medica…
View article: United Kingdom artificial nutrition database: The changing landscape of adult home parenteral support
United Kingdom artificial nutrition database: The changing landscape of adult home parenteral support Open
Background The United Kingdom nutrition database monitors the changing landscape of adult home parenteral nutrition support (HPS) to inform clinicians and policy makers of the need for this life‐saving treatment. Methods The UK database is…
View article: A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort
A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort Open
Background The success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of Sars-CoV-2 infection may predominantly reflect its anti-inflammatory action against a hyperinflammation (HI) response. It is likely that …
View article: Long overdue: undergraduate nutrition education for medical students
Long overdue: undergraduate nutrition education for medical students Open
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.
View article: Optimisation of COVID‐19 diagnostic pathways in acute hospital admissions to prevent nosocomial transmission
Optimisation of COVID‐19 diagnostic pathways in acute hospital admissions to prevent nosocomial transmission Open
Introduction In the management of acute hospital admissions during the COVID‐19 pandemic, safe patient cohorting depends on robust admission diagnostic strategies. It is essential that screening strategies are sensitive and rapid, to preve…
View article: Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation study
Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation study Open
Introduction Patients with suspected inflammatory bowel disease (IBD) referred from primary care often face diagnostic and treatment delays. This study aimed to compare a novel direct-access IBD endoscopy pathway with the traditional care …
View article: Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19
Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19 Open
View article: Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS] Open
Background and Aims Subcutaneous [SC] vedolizumab presents the opportunity for inflammatory bowel disease [IBD] patients to manage their treatment at home. There are currently no data on the process of transitioning patients established on…
View article: PMO-15 Transitioning from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease (TRAVELESS)
PMO-15 Transitioning from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease (TRAVELESS) Open
Introduction In May 2020, subcutaneous (SC) vedolizumab was approved for use in Inflammatory Bowel Disease (IBD). Patients with IBD have a number of risk factors for a poor outcome from SARS-CoV-2 infection and managing this risk by reduci…
View article: Powered Respirators Are Effective, Sustainable, and Cost-Effective Personal Protective Equipment for SARS-CoV-2
Powered Respirators Are Effective, Sustainable, and Cost-Effective Personal Protective Equipment for SARS-CoV-2 Open
Objectives: The provision of high-quality personal protective equipment (PPE) has been a critical challenge during the COVID-19 pandemic. We evaluated an alternative strategy, mass deployment of a powered air-purifying respirator (PeRSo), …
View article: Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality
Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality Open
View article: Supporting people who have eating and drinking difficulties
Supporting people who have eating and drinking difficulties Open
Eating and drinking are essential for maintenance of nutrition and hydration, but are also important for pleasure and social interactions. The ability to eat and drink hinges on a complex and coordinated system, resulting in significant po…
View article: A novel hyperinflammation clinical risk tool, HI5-NEWS2, predicts mortality following early dexamethasone use in an observational cohort of hospitalised COVID-19 patients
A novel hyperinflammation clinical risk tool, HI5-NEWS2, predicts mortality following early dexamethasone use in an observational cohort of hospitalised COVID-19 patients Open
Background The success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of Sars-CoV-2 infection may predominantly reflect its anti-inflammatory action against a hyperinflammation (HI) response. It is likely that …
View article: Malnutrition risk in hospitalised COVID-19 patients receiving CPAP
Malnutrition risk in hospitalised COVID-19 patients receiving CPAP Open
View article: Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management
Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management Open
View article: O69 Outcome of direct access IBD physician delivered endoscopy for general practice referrals with suspected IBD
O69 Outcome of direct access IBD physician delivered endoscopy for general practice referrals with suspected IBD Open
Introduction: patients with suspected IBD referred by primary care (GP) are traditionally seen in gastroenterology outpatient clinics followed by endoscopic investigations. This 2 phase model leads to delay in diagnosis and treatment, incr…
View article: P286 Hit and miss? The monitoring of intestinal failure associated liver disease
P286 Hit and miss? The monitoring of intestinal failure associated liver disease Open
Introduction Intestinal failure associated liver disease (IFALD) is a complication in patients with intestinal failure (IF) on home parenteral nutrition (HPN). It can progress to cirrhosis requiring a combined liver-intestinal transplant w…
View article: A Novel Hyperinflammation Clinical Risk Tool, HI5-NEWS2, Predicts Mortality Following Early Dexamethasone Use in an Observational Cohort of Hospitalised COVID-19 Patients
A Novel Hyperinflammation Clinical Risk Tool, HI5-NEWS2, Predicts Mortality Following Early Dexamethasone Use in an Observational Cohort of Hospitalised COVID-19 Patients Open
View article: P168 Tofacitinib in ulcerative colitis: early real-world experience in Southampton
P168 Tofacitinib in ulcerative colitis: early real-world experience in Southampton Open
Introduction The landscape of medical therapies for severe ulcerative colitis is widening. Tofacitinib, the first oral therapy and Janus kinase (JAK) inhibitor to be approved for this indication, was licensed in the EU in August 2018 and w…
View article: P285 Are there new tools to assess fibrosis in IFALD?
P285 Are there new tools to assess fibrosis in IFALD? Open
Introduction Intestinal failure associated liver disease (IFALD) refers to liver injury due to intestinal failure (IF) and parenteral nutrition (PN). This presents as steatosis and cholestasis which can lead to fibrosis and cirrhosis. ESPE…